News

5 November 2024

The Button Mushroom: A genuine innovation for Osteoarthritis treatment?

Read more
17 September 2024

The daily battle against Osteoarthritis: Jocelyne’s Story

Read more
5 September 2024

Treatment of patients suffering from Osteoarthritis in China

Read more
31 May 2024

KiOmed Pharma celebrates treating its 20,000th patient and looks to the future with optimism

Read more
14 November 2023

Refractory Osteoarthritis: insights on the challenges

Read more
17 September 2023

KiOmed Pharma and Arsylab Announce Strategic Partnership for the Promotion and Distribution in France of KioMedinevsone, a New Class of Treatment for Refractory Knee Osteoarthritis

Read more
8 August 2023

We are always looking for talented people

Read more
26 September 2022

KiOmed Pharma and Hansoh Pharma Announce License Agreement for KioMedinevsone in China’s Mainland, Macau and Taiwan

Read more
10 May 2022

Using fungi to slow down cellular ageing

Read more
7 October 2021

KiOmed Pharma and Sinclair Pharma sign an exclusive partnership based on “KiOmedine®” technology

Read more
3 June 2021

KiOmed Pharma and moveUP Partner to Develop and Market a Companion Healthcare Application for Personalised Treatment of Osteoarthritis

Read more
24 May 2021

KiOmed Pharma reports promising long-term results in a new European multi centric survey Treatment of Advanced Knee OsteoArthritis

Read more
24 June 2020

KiOmed Pharma appoints seasoned industry executives and expands its board of directors

Read more
5 May 2020

KiOmed Pharma obtains CE mark and signs a License and Supply Agreement

Read more